eFFECTOR Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EFTR and other ETFs, options, and stocks.

About EFTR

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2).

CEO

Stephen T. Worland

CEOStephen T. Worland

Employees

Employees14

Headquarters

Solana Beach, California

HeadquartersSolana Beach, California

Founded

2012

Founded2012

Employees

Employees14

EFTR Key Statistics

Market cap

6.56M

Market cap6.56M

Price-Earnings ratio

-0.10

Price-Earnings ratio-0.10

Dividend yield

—

Dividend yield—

Average volume

639.97K

Average volume639.97K

High today

—

High today—

Low today

—

Low today—

Open price

$1.91

Open price$1.91

Volume

0.00

Volume0.00

52 Week high

$37.00

52 Week high$37.00

52 Week low

$1.75

52 Week low$1.75